Ridgewood Investments’s Covetrus, Inc. Common Stock CVET Stock Holding History

Ridgewood Investments’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,600	Closed	-$200K	–	209
2022 Q3	$200K	Buy	+9,600	New	+$200K	0.17%	166
2021 Q3	–	Sell	-9,600	Closed	-$259K	–	203
2021 Q2	$259K	Hold	9,600	–	–	0.17%	159
2021 Q1	$288K	Hold	9,600	–	–	0.18%	154
2020 Q4	$234K	Hold	9,600	–	–	0.18%	144
2020 Q3	$234K	Buy	+9,600	New	+$207K	0.18%	145
2020 Q1	–	Sell	-10,880	Closed	-$144K	–	207
2019 Q4	$144K	Hold	10,880	–	–	0.1%	183
2019 Q3	$129K	Hold	10,880	–	–	0.1%	171
2019 Q2	$266K	Hold	10,880	–	–	0.21%	139
2019 Q1	$347K	Buy	+10,880	New	+$386K	0.29%	115

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ridgewood Investments's CVET Position: Q4 2022 in Review

Ridgewood Investments sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 9,600 shares — an estimated $200K sold.

Ridgewood Investments first reported a position in CVET in Q1 2019 and held it in 9 quarters. The position peaked at $347K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Ridgewood Investments reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Ridgewood Investments sold 9,600 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $200K.
Ridgewood Investments first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
Ridgewood Investments's Covetrus, Inc. Common Stock position peaked at $347K in Q1 2019.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Ridgewood Investments's 13F filing for Q4 2022, filed 19 Jan 2023.